July 9, 2025

Is Spirulina the Next Anti-Aging Superfood?

By Vijay Kumar MalesuReviewed by Benedette Cuffari, M.Sc. Introduction What is Spirulina? Bioactive components Mechanisms of action Industry and applications Safety and limitations Conclusion References Further reading Discover how Spirulina’s unique blend of proteins, pigments, and polyphenols makes it a powerful ally against oxidative stress, inflammation, and cellular aging while offering sustainable nutrition for the future. Spirulina, […]

Is Spirulina the Next Anti-Aging Superfood? Read More »

AI used to create protein that kills E. coli

July 9, 2025 / Research update / InnovateMed Author / E.coli

Australian scientists have used Artificial Intelligence (AI) to generate a ready-to-use biological protein that can kill antibiotic resistant bacteria like E. coli. Peer-Reviewed Publication Monash University FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail In the last year, there has been a surge in proteins developed by AI that will eventually be used in the treatment of everything from snakebites to cancer.

AI used to create protein that kills E. coli Read More »

The brain can selectively recognize glucose, offering clues to treat obesity and diabetes

July 9, 2025 / Research update / InnovateMed Author / diabetes, glucose, obesity

by The Korea Advanced Institute of Science and Technology (KAIST) edited by Lisa Lock, reviewed by Robert Egan Credit: Neuron (2025). DOI: 10.1016/j.neuron.2025.05.024 Starting with the question “How does our brain distinguish glucose from the many nutrients absorbed in the gut?” a KAIST research team has demonstrated that the brain can selectively recognize specific nutrients—particularly glucose—beyond simply detecting total

The brain can selectively recognize glucose, offering clues to treat obesity and diabetes Read More »

‘Harmless’ virus might trigger Parkinson’s disease, researchers say

July 9, 2025 / Research update / InnovateMed Author / Parkinson disease

by Dennis Thompson edited by Sadie Harley, reviewed by Robert Egan A common virus once thought harmless to humans might be linked to Parkinson’s disease, a new study says. The germ, Human Pegivirus (HPgV), was found in half the autopsied brains of patients with Parkinson’s, but not in any brains from healthy people, researchers report in the

‘Harmless’ virus might trigger Parkinson’s disease, researchers say Read More »

Universal stem cells reset immunity in a systemic sclerosis patient

July 9, 2025 / Research update / InnovateMed Author / systemic sclerosis

by Justin Jackson, Phys.org edited by Sadie Harley, reviewed by Robert Egan Graphical abstract. Credit: Cell (2025). DOI: 10.1016/j.cell.2025.05.038 Research led by Naval Medical University’s Changzheng Hospital in China reports that an off-the-shelf cell therapy built from induced pluripotent stem cells (iPSCs) loosened life-limiting skin and organ scarring in a woman with systemic sclerosis. Systemic sclerosis progressively suffocates tissue

Universal stem cells reset immunity in a systemic sclerosis patient Read More »

National review identifies most effective skincare ingredients for common skin issues

July 9, 2025 / Patient education / InnovateMed Author / skin issues

by Northwestern University edited by Sadie Harley, reviewed by Andrew Zinin Credit: Unsplash/CC0 Public Domain From drugstore aisles to TikTok trends, consumers are bombarded with skincare products. But how do you know what really works, especially now with summer in full swing? A Northwestern Medicine study offers clarity, identifying the ingredients that dermatologists agree are most effective for seven common

National review identifies most effective skincare ingredients for common skin issues Read More »

Genome editing enables mice to produce their own weight-loss drug for months

July 9, 2025 / Research update / InnovateMed Author / Weight loss

by University of Osaka edited by Sadie Harley, reviewed by Robert Egan System for in vivo genome editing–mediated exenatide production and its therapeutic application in obese mice. Credit: Keiichiro Suzuki Weight-loss drugs have surged in popularity, promising rapid results with regular injections. Now, researchers from Japan report a way for the body to make its own weight-loss

Genome editing enables mice to produce their own weight-loss drug for months Read More »

Creatine may help the brain, not just muscles

July 9, 2025 / Research update / InnovateMed Author / creatine

Fralin Biomedical Research Institute team is working to get creatine past the blood-brain barrier using focused ultrasound. Grant and Award AnnouncementVirginia Tech FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail image: Chin-Yi Chen, a research scientist at Virginia Tech’s Fralin Biomedical Research Institute, works in assistant professor Fred Wu’s lab to develop a technique that uses focused ultrasound to deliver creatine directly

Creatine may help the brain, not just muscles Read More »

Scientists reveal how a key inflammatory molecule triggers esophageal muscle contraction

July 9, 2025 / Research update / InnovateMed Author / oesophageal muscle contraction

by Toho University edited by Sadie Harley, reviewed by Andrew Zinin The contractile responses of esophageal smooth muscle (SM) induced by platelet-activating factor (PAF) involve the activation of L-type voltage-dependent calcium channels (L-type VDCCs), receptor-operated calcium channels (ROCCs), and store-operated calcium channels (SOCCs), with Orai1 serving as a key component of the SOCC pathway. Credit: Keisuke Obara A

Scientists reveal how a key inflammatory molecule triggers esophageal muscle contraction Read More »

Cellular signature explains why some prostate tumors resist standard treatments

July 9, 2025 / Research update / InnovateMed Author / prostate tumors

by Nicole Fawcett, University of Michigan edited by Sadie Harley, reviewed by Robert Egan Extreme non-response patients have distinct transcriptional profiles. Credit: npj Precision Oncology (2025). DOI: 10.1038/s41698-025-01002-8 A new study by University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment. Treatments such as

Cellular signature explains why some prostate tumors resist standard treatments Read More »